Tennis Star Alisa Kleybanova Diagnosed with Lymphoma
The No. 28-ranked tennis player in the world, Alisa Kleybanova, has been diagnosed with Hodgkin’s lymphoma.
The Russian tennis star, who celebrated her 22nd birthday this past Friday, released a statement on the matter addressing her fans and supporters. In the message she spoke of her plans for both the immediate future, and long-term.
"It's my birthday today and I want to thank all of you for the wonderful messages. I haven't written anything for a long time about why I haven't been on tour, so that's why I'm writing this today," she said in a statement.
"It's not an easy time for me right now. I've been a bit unlucky with my health. I have Hodgkin's Lymphoma, a form of cancer.
"I've been having treatment in Italy and it has been going well, but it takes lots of patience and I've had to be really strong to get through this. The good news is after I do treatment for a few more months, if I feel well, there's a chance I'll be able to play tennis again.
"I really miss playing - I miss seeing fans and friends around the world, I miss hitting the ball, I miss everything. Tennis has been my life for the last 15 years.
"There are a few reasons I'm undergoing treatment in Italy. First, I have a training base and many close friends here, so it's like home," she said.
"Second, they have a really great hospital here that specializes in this problem; I've been going there since the problem started, so the doctors know me well. It's the best place for me to be - the surroundings help me stay strong.
"This is the toughest time in my life, and I hope it always stays the toughest time in my life. I'm sure I'll be able to overcome this - it's just a matter of patience and time. When this is over, everything will be even better than before.
"I won't be on tour for a little while, but I will see you all again soon."
The WTA, for their part, expressed their complete and outright respect for Kleybanova and the courage she was exhibiting.
"The thoughts of the WTA and the entire tennis family are with Alisa and her family at this difficult time," said a WTA statement.
"Alisa is a very strong and optimistic person and we wish her a speedy and full recovery."
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
